The treatment of amblyopia

Strabismus

Volumn 14, Issue 1, 2006, Pages 37-42

  Holmes, Jonathan ^a   Repka, Michael ^b   Kraker, Raymond ^c   Clarke, Michael ^d  

^a Mayo Clinic   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JAEB CENTER FOR HEALTH RESEARCH   (United States)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Amblyopia treatment; Anisometropia; Atropine; Patching; Pediatric ophthalmology; Spectacles; Visual acuity

Indexed keywords

ATROPINE;

AMBLYOPIA; ANISOMETROPIA; CHILD PARENT RELATION; CLINICAL TRIAL; CONFERENCE PAPER; EYE REFRACTION; FOLLOW UP; HUMAN; MONOTHERAPY; OUTCOME ASSESSMENT; PEDIATRICS; PRIORITY JOURNAL; SPECTACLES; STRABISMUS; VISION; VISUAL ACUITY;

AMBLYOPIA; ATROPINE; DECISION MAKING; EYEGLASSES; HUMANS; PARASYMPATHOLYTICS; SENSORY DEPRIVATION; TREATMENT OUTCOME;

EID: 33644782635     PISSN: 09273972     EISSN: 17445132     Source Type: Journal    
DOI: 10.1080/09273970500536227     Document Type: Conference Paper

References (20)

1. Awan M, Proudlock FA, Gottlob I. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci. 2005;46:1435-1439.
2. Beck RW. The pediatric eye disease investigator group. J AAPOS. 1998;2:255-256.
3. Clarke MP, Wright CM, Hrisos S, et al. Randomised controlled trial of treatment of unilateral visual impairment detected at preschool vision screening. Br Med J. 2003;327:1251-1256.
4. Cole SR, Beck RW, Moke PS, et al. The Amblyopia Treatment Index. J AAPOS. 2001;5:250-254.
5. Holmes JM, Beck RW, Repka MX, et al. The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol. 2001;119:1345-1353.
6. Moseley MJ, Neufeld M, Fielder AR. Treatment of amblyopia by spectacles. Ophthalmic Physiol Opt. 2002;22:296-299.
7. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120:268-278.
8. Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study. Am J Ophthalmol. 2003a;136:630-639.
9. Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003b;121:603-611.
10. Pediatric Eye Disease Investigator Group. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol. 2003c;121:1625-1632.
11. Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003d;110:2075-2087.
12. Pediatric Eye Disease Investigator Group. Risk of amblyopia recurrence after cessation of treatment. J AAPOS. 2004a;8:420-428
13. Pediatric Eye Disease Investigator Group. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology. 2004b;111:2076-2085.
14. Pediatric Eye Disease Investigator Group. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2005a;123:149-157.
15. Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005b;123:437-447.
16. Pediatric Eye Disease Investigator Group. A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia. J AAPOS. 2005c;9:129-136.
17. Stewart CE, Moseley MJ, Fielder AR, Stephens DA, MOTAS Cooperative. Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol. 2004a;88:1552-1556.
18. Stewart CE, Moseley MJ, Stephens DA, Fielder AR. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci. 2004b;45:3048-3054.
19. Stewart CE, Fielder AR, Stephens DA, Moseley MJ. Treatment of unilateral amblyopia: factors influencing visual outcome. Invest Ophthalmol Vis Sci. 2005a;46:3152-3160.
20. Stewart CE, Moseley MJ, Stephens DA, Fielder AR, ROTAS Cooperative. Modelling of treatment dose-response in amblyopia. Invest Ophthalmol Vis Sci. 2005b;46:E-abstr. 3595.